Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib in Oral Leukoplakia
NCT00101335Phase 2Completed
- Sponsor
- Fox Chase Cancer Center
- Start
- Nov 2003
- Primary completion
- Jan 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib in oral leukoplakia, sponsored by Fox Chase Cancer Center. Started Nov 2003; status: completed.
02
Drugs
celecoxib
03
Conditions
oral leukoplakia
Beyond the preview
Go deeper on NCT00101335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00101335.